Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Indomethacin inhibits PGE2, regulates inflammatory response, participates in adipogenesis regulation, and improves success rate of fat transplantation in C57/B6 mice

Hongyu Xue1, Hongyi Zhao , Huiying Wang3, Song Zhang1

1Department of Plastic Surgery, Peking University Third Hospital; 2Department of Plastic Surgery, Beijing Hospital, National Center of Gerontology; 3Department of Burns and Plastic Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing, PR China.

For correspondence:-  Hongyi Zhao   Email: ethj78@163.com

Accepted: 30 October 2019        Published: 30 November 2019

Citation: Xue H, Zhao H, Wang H, Zhang S. Indomethacin inhibits PGE2, regulates inflammatory response, participates in adipogenesis regulation, and improves success rate of fat transplantation in C57/B6 mice. Trop J Pharm Res 2019; 18(11):2313-2318 doi: 10.4314/tjpr.v18i11.12

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of indomethacin on prostaglandin E2, regulation of inflammation and adipogenesis, and success of fat transplantation in mice.
Methods: The mice were randomly divided into 4 groups: group A (free fat group), group B (free fat + stromal vascular fragments group (SVF)), group C (free fat + 200 μM indomethacin group), and group D (free fat + 200 μM indomethacin + SVF group), with 21 mice in each group. expression levels of adipogenic genes CEBP-α, FABP4 and LPL in each group were determined. Changes in PGE2 level in transplanted adipose tissue, and changes in the expression of NF-κB in apoptotic stem cells induced by different pro-inflammatory treatments were assayed.
Results: Compared with group B, the expression levels of adipogenic genes CEBP-α, FABP4 and LPL significantly decreased in groups A, C and D, with group A as the lowest (p < 0.05). Compared with the indomethacin treatment group, the level of inhibition of PGE2 in mice adipose tissue in the indomethacin-free group increased significantly (p < 0.01). The expression of NF-κB in the adipose stem cells from the indomethacin-treated group was significantly lower than that in the indomethacin-treated group after pretreatment with IL-17 or INF-γ + TNF-α.
Conclusion: Indomethacin regulates adipogenesis by inhibiting the production of COX2 metabolite, PGE2. It also regulates the local microenvironment, inhibits the inflammatory process, and protects various stem cells. Therefore, it may improve the success rate of fat transplantation.

Keywords: Indomethacin, PGE2, Wnt signaling pathway, adipogenic regulation, fat transplantation success

Impact Factor
Thompson Reuters (ISI): 0.523 (2021)
H-5 index (Google Scholar): 39 (2021)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates